STEINMAN LAWRENCE - 02 Jun 2023 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role: Director
Signature: /s/ Larry Steinman
Issuer symbol: KTTA
Transactions as of: 02 Jun 2023
Transactions value $: $12,930
Form type: 4
Filing time: 06 Jun 2023, 21:00:08 UTC
Previous filing: 02 Jun 2023
Next filing: 15 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KTTA	Common Stock	Purchase	$12,930	+30,000	+2.31%	$0.4310	1,327,174	02 Jun 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.38 to $0.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.38 to $0.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.